119 related articles for article (PubMed ID: 30594073)
1. miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair.
Lu Y; Song S; Jiang X; Meng Q; Wang C; Li X; Yang Y; Xin X; Zheng Q; Wang L; Pu H; Gui X; Li T; Lu D
Mol Ther Nucleic Acids; 2019 Mar; 14():171-183. PubMed ID: 30594073
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.
Yang Y; Meng Q; Wang C; Li X; Lu Y; Xin X; Zheng Q; Lu D
J Mol Med (Berl); 2018 Oct; 96(10):1119-1130. PubMed ID: 30140938
[TBL] [Abstract][Full Text] [Related]
4. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
[TBL] [Abstract][Full Text] [Related]
5. H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells.
Wang L; Niu N; Li L; Shao R; Ouyang H; Zou W
PLoS Biol; 2018 Nov; 16(11):e2006522. PubMed ID: 30422989
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling.
Xin X; Wang C; Lin Z; Xu J; Lu Y; Meng Q; Li X; Yang Y; Zheng Q; Gui X; Li T; Pu H; Xiong W; Li J; Jia S; Lu D
Mol Ther Nucleic Acids; 2018 Jun; 11():367-381. PubMed ID: 29858072
[TBL] [Abstract][Full Text] [Related]
7. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Skucha A; Ebner J; Grebien F
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
[TBL] [Abstract][Full Text] [Related]
8. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.
Ho TH; Park IY; Zhao H; Tong P; Champion MD; Yan H; Monzon FA; Hoang A; Tamboli P; Parker AS; Joseph RW; Qiao W; Dykema K; Tannir NM; Castle EP; Nunez-Nateras R; Teh BT; Wang J; Walker CL; Hung MC; Jonasch E
Oncogene; 2016 Mar; 35(12):1565-74. PubMed ID: 26073078
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers.
Chen R; Zhao WQ; Fang C; Yang X; Ji M
J Cancer; 2020; 11(11):3349-3356. PubMed ID: 32231741
[TBL] [Abstract][Full Text] [Related]
10. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
[TBL] [Abstract][Full Text] [Related]
11. [Histone H3 lysine 9 methylation is associated with the expression of hMLH1 and DNA methylation in gastric cancer cells].
Meng CF; Zhu XJ; Peng G
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2490-3. PubMed ID: 19080631
[TBL] [Abstract][Full Text] [Related]
12. On your mark, get SET(D2), go! H3K36me3 primes DNA mismatch repair.
Schmidt CK; Jackson SP
Cell; 2013 Apr; 153(3):513-5. PubMed ID: 23622237
[TBL] [Abstract][Full Text] [Related]
13. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract][Full Text] [Related]
14. Interplay between histone H3 lysine 56 deacetylation and chromatin modifiers in response to DNA damage.
Simoneau A; Delgoshaie N; Celic I; Dai J; Abshiru N; Costantino S; Thibault P; Boeke JD; Verreault A; Wurtele H
Genetics; 2015 May; 200(1):185-205. PubMed ID: 25786853
[TBL] [Abstract][Full Text] [Related]
15. Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells.
Sankaran SM; Gozani O
Epigenetics; 2017; 12(11):917-922. PubMed ID: 28933651
[TBL] [Abstract][Full Text] [Related]
16. Promoter-exon relationship of H3 lysine 9, 27, 36 and 79 methylation on pluripotency-associated genes.
Barrand S; Andersen IS; Collas P
Biochem Biophys Res Commun; 2010 Oct; 401(4):611-7. PubMed ID: 20920475
[TBL] [Abstract][Full Text] [Related]
17. Previously uncharacterized amino acid residues in histone H3 and H4 mutants with roles in DNA damage repair response and cellular aging.
Thakre PK; Sv A; Golla U; Chauhan S; Tomar RS
FEBS J; 2019 Mar; 286(6):1154-1173. PubMed ID: 30536627
[TBL] [Abstract][Full Text] [Related]
18. DNA mismatch repair genes in renal cell carcinoma.
Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
[TBL] [Abstract][Full Text] [Related]
19. Methylation of histone H3 lysine-79 by Dot1p plays multiple roles in the response to UV damage in Saccharomyces cerevisiae.
Bostelman LJ; Keller AM; Albrecht AM; Arat A; Thompson JS
DNA Repair (Amst); 2007 Mar; 6(3):383-95. PubMed ID: 17267293
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies.
Chao A; Lin CY; Chao AN; Tsai CL; Chen MY; Lee LY; Chang TC; Wang TH; Lai CH; Wang HS
Oncotarget; 2017 Sep; 8(43):74434-74450. PubMed ID: 29088798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
